Oystershell builds anti-lice portfolio with RID deal

27 July 2020 - Deborah Wilkes

Premium

Belgian consumer healthcare company Oystershell has acquired Bayer’s RID brand of lice treatments in the US for an undisclosed sum. Chief executive officer Mike Van Ganse told OTCToolbox the company is seeking further acquisitions in Europe and North America.

Click tags below for more information on topics:

Oystershell

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: